• Home
  • About Us
  • Leadership Team
  • news
  • Careers
  • facility
  • Contact Us
  • news
  • Careers
  • facility
  • Contact Us
  • Home
  • About Us
  • Leadership Team
  • CAREERS

You are here

Home » News

News

Therapure Biomanufacturing Signs Manufacturing Deal With VBI Vaccines for Coronavirus Vaccine Candidates
08/18/2020
Therapure Biomanufacturing Announces U.S. FDA Approval for Manufacturing of its Partner Insmed’s ARIKAYCE®
10/04/2018
Therapure Biopharma Inc. Wins the Mississauga Board of Trade’s 2017 Business Awards of Excellence
12/04/2017
Therapure Biopharma Inc. Announces Spin Off and Sale of Contract Development and Manufacturing Business for US$290 Million
09/06/2017
For a third consecutive year Therapure Biopharma Inc. ranks in the PROFIT 500 list of the Fastest-Growing Companies in Canada and ranks 10th in the GTA manufacturing sector (2nd largest employer).
05/05/2017
Therapure Biomanufacturing Receives 2017 CMO Leadership Individual Attribute Awards for Capabilities and Staff Characteristics
03/24/2017
Therapure Biopharma Inc. welcomes delegation from all three levels of government to its state-of-the-art facility
05/10/2016
Therapure Biopharma Inc. Postpones Initial Public Offering
02/09/2016
Therapure Biopharma Inc. Files Preliminary Prospectus for Initial Public Offering
11/26/2015
For a second consecutive year Therapure Biopharma Inc. ranks in the top 100 of the PROFIT 500 list of the Fastest-Growing Companies in Canada, and ranks 18th on the list of Canada’s Fastest-Growing Manufacturing Companies
09/29/2015

Pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • next ›
  • last »
  • News

Disclaimer | Privacy Policy | Contact Us | Accessibility
Privacy Policy | HTML Site Map

Vendor/Supplier Purchase Terms and Conditions
Copyright ©2015 Therapure Biopharma Inc.
Therapure Biomanufacturing, Therapure Innovations and Evolve Biologics are divisions of Therapure Biopharma Inc.

EVENTS

more

NEWS

more

awards

more
☒

Therapure CDMO is now a part of Resilience!

The CDMO assets of Therapure Biopharma Inc have been acquired by Resilience Biotechnologies, Inc., a wholly owned Canadian subsidiary of National Resilience, Inc. (Resilience), a U.S. based biopharmaceutical manufacturing and technology company.


We remain committed to supporting you as Resilience Biotechnologies Inc.




For more information about Resilience, please visit: https://resilience.com




MAKING THE FUTURE OF MEDICINE POSSIBLE